Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the effect of four weeks treatment with EGb761® in comparison to placebo in three groups of elderly : MC, AD and CNE. The primary endpoint will be the change in brain glucose metabolism at M1 versus baseline as measured using 18 FDG-PET.
Inclusion criteria
- patients with either spontaneous memory complaint with ou without cognitive impairment or with newly diagnosed mild Alzheimer’s disease